Vir Biotechnology (VIR) Stock Chart & Stock Price History $7.03 -0.98 (-12.23%) (As of 11/18/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Vir Biotechnology Stock Price Performance 5 Day Performance-18.63%1 Month Performance-7.86%3 Month Performance-19.84%6 Month Performance-27.75%Year-To-Date Performance-30.12%1 Year Performance-27.45% Receive VIR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vir Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address Download Our Tesla Ebook For Free (Ad)Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. VIR Stock Chart for Tuesday, November, 19, 2024 VIR Chart by TradingView Vir Biotechnology Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/18/2024$8.01$7.03-12.23%$8.02$7.002.24 million shs$968.17 million11/15/2024$8.64$8.01-7.29%$8.70$7.861.48 million shs$1.10 billion11/14/2024$8.98$8.64-3.79%$9.10$8.63766,063 shs$1.19 billion11/13/2024$9.25$8.98-2.92%$9.43$8.96696,896 shs$1.24 billion11/12/2024$9.87$9.25-6.28%$9.75$9.161.09 million shs$1.27 billion11/11/2024$9.60$9.87+2.81%$10.13$9.61817,355 shs$1.36 billion Get the Latest News and Ratings for VIR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vir Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 11/08/2024$9.77$9.60-1.74%$9.81$9.48940,481 shs$1.32 billion11/07/2024$10.17$9.77-3.93%$10.30$9.75901,957 shs$1.35 billion11/06/2024$9.64$10.17+5.50%$10.44$9.522.14 million shs$1.39 billion11/05/2024$9.37$9.64+2.88%$9.65$9.201.11 million shs$1.32 billion11/04/2024$9.26$9.37+1.19%$9.51$9.021.55 million shs$1.28 billion11/01/2024$7.49$9.26+23.63%$9.73$7.147.29 million shs$1.27 billion10/31/2024$7.60$7.49-1.45%$7.66$7.451.27 million shs$1.02 billion10/30/2024$7.61$7.60-0.13%$7.82$7.53802,362 shs$1.04 billion10/29/2024$7.75$7.61-1.81%$7.78$7.56780,604 shs$1.04 billion10/28/2024$7.48$7.75+3.61%$7.92$7.501.90 million shs$1.06 billion10/25/2024$7.35$7.48+1.77%$7.76$7.361.11 million shs$1.02 billion10/24/2024$7.52$7.35-2.26%$7.53$7.24732,608 shs$1.00 billion10/23/2024$7.61$7.52-1.18%$7.68$7.50851,531 shs$1.02 billion10/22/2024$7.65$7.61-0.52%$7.69$7.48623,216 shs$1.04 billion10/21/2024$7.63$7.65+0.26%$7.76$7.57747,249 shs$1.05 billion10/18/2024$7.72$7.63-1.17%$7.80$7.56451,389 shs$1.04 billion Related Companies FATE Stock Price Chart BLUE Stock Price Chart CRSP Stock Price Chart IMVT Stock Price Chart DNLI Stock Price Chart IBRX Stock Price Chart KYMR Stock Price Chart SWTX Stock Price Chart VCEL Stock Price Chart IOVA Stock Price Chart Receive VIR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vir Biotechnology and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VIR) was last updated on 11/19/2024 by MarketBeat.com Staff From Our PartnersTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vir Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vir Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
